Apollo Hospitals Enterprise dividend and valuation
Valuation
Apollo Hospitals Enterprise paid ₹20.00 per share in dividends over the last 12 months (yield 0.2%). Last ex-dividend date: August 14, 2026. The P/E ratio is 58.8. The average price target of 30 analysts is ₹9,970.60.
Data as of November 22, 2026
Apollo Hospitals Enterprise compared with similar companies
Apollo Hospitals Enterprise's P/E (trailing 12 months): 58.8, +102% against the median of a group of 11 similar companies (29.1).
| Metric | Apollo Hospitals Enterprise | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 58.8 | 29.1 | 19.2 – 48.4 | High |
| Forward P/E | 42.0 | 20.1 | 16.3 – 32.0 | High |
| EV/EBITDA | 35.1 | 14.4 | 9.30 – 26.3 | High |
| Price/book | 12.5 | 3.99 | 3.16 – 6.93 | High |
| Price/sales | 4.75 | 2.07 | 1.00 – 4.76 | Middle |
| Gross margin | 35.5% | 35.5% | 25.3% – 44.9% | Middle |
| Operating margin | 12.1% | 17.1% | 10.5% – 19.4% | Middle |
| Net margin | 8.1% | 8.1% | 7.5% – 10.5% | Middle |
| ROE | 22.5% | 17.1% | 10.7% – 21.1% | High |
| Debt/equity | 0.73 | 0.79 | 0.53 – 0.98 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Apollo Hospitals Enterprise: valuation over time
On the latest fiscal year's earnings (2026), Apollo Hospitals Enterprise's P/E today is 68.2, in line with the median of its last 10 fiscal years (71.6; between 34.8 and 270.3 from 2017 to 2026). Relative to earnings, it costs about the same as in the past. The dividend yield (0.2%) is below the median of the last 10 fiscal years (0.3%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| Mar 2026 | ₹7,419.00 | ₹134.94 | 55.0 | ₹20.00 | 0.3% |
| Mar 2025 | ₹6,616.20 | ₹100.56 | 65.8 | ₹19.00 | 0.3% |
| Mar 2024 | ₹6,356.80 | ₹62.50 | 101.7 | ₹16.00 | 0.3% |
| Mar 2023 | ₹4,310.90 | ₹56.97 | 75.7 | ₹15.00 | 0.3% |
| Mar 2022 | ₹4,516.10 | ₹73.42 | 61.5 | ₹11.75 | 0.3% |
| Mar 2021 | ₹2,902.65 | ₹10.74 | 270.3 | ₹3.00 | 0.1% |
| Mar 2020 | ₹1,139.05 | ₹32.70 | 34.8 | ₹6.00 | 0.5% |
| Mar 2019 | ₹1,182.95 | ₹16.96 | 69.7 | ₹6.00 | 0.5% |
| Mar 2018 | ₹1,064.65 | ₹8.44 | 126.1 | ₹5.00 | 0.5% |
| Mar 2017 | ₹1,165.15 | ₹15.88 | 73.4 | ₹6.00 | 0.5% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- ₹1.32T
- Enterprise value
- ₹1.39T
- EV/revenue
- 4.98
Profitability and growth
- ROA
- 9.1%
- ROIC
- 11.4%
- Revenue growth (year over year)
- 20.8%
- Earnings growth (year over year)
- 31.9%
Financial health
- Total cash
- ₹23.81B
- Total debt
- ₹81.49B
- Current ratio
- 1.12
- Quick ratio
- 0.90
Dividends
- Annual dividend per share
- ₹20.00
- Dividend yield
- 0.2%
- Payout ratio
- 12.8%
- Ex-dividend date
- August 14, 2026
Analysts and estimates
- Average price target
- ₹9,970.60
- Median price target
- ₹10,154.00
- High price target
- ₹10,770.00
- Low price target
- ₹7,570.00
- Analysts with a price target
- 30
- Consensus
- Strong buy
- Forward EPS
- ₹218.80
- EPS estimate, current year
- ₹172.10
Shares and trading
- Beta
- 0.25
- Average volume
- 508.55K
- Shares outstanding
- 143.78M
- Float
- 99.58M
- Institutional ownership
- 50.8%
- Insider ownership
- 28.4%
